Press Center
Olympus Introduces A New Line of Next Generation Urology Products
Orangeburg, NY, June 6, 2006 - Olympus, a global leader in designing and delivering advanced and innovative healthcare solutions, has introduced a new line of next generation urology products at the 2006 American Urological Association (AUA) annual meeting.
The new family of products is based on Olympus’ proven imaging technology and includes: the worlds first and only Semi-Rigid Video Ureteroscope, the CYF-V2 Cysto-Nephro Videoscope, the URF-P5 Uretero-Reno-Fiberscope with 275 deflection for lower pole access, the OES Pro Ureteroscope with an increased 50k fiber count, and the longer Percutaneous Nephroscope designed for both small and large patients. The table below identifies some of the main features and benefits of these new and exciting products.
Features and Benefits:Semi-Rigid Video Ureteroscope
|
CYF-V2 Cysto-Nephro Videoscope
|
URF-P5 Uretero-Reno-Fiberscope
|
OES Pro Ureteroscope
|
OES Pro Percutaneous Nephroscope
|
Olympus’ new urology line introduces urologists to the next generation of products designed for improved patient care. With the introduction of these products, Olympus continues to display the company’s long-standing commitment to advancing endoscopic technology in the urology market. Additionally, the new urology product line is equipped with the latest technology and is positioned to offer urologists a new experience in efficiency, performance, and functionality.
About Olympus Surgical America
Olympus Surgical America is an operating division of Olympus Surgical & Industrial America
Inc, a wholly owned subsidiary of Olympus Corporation, Japan. Olympus Surgical America is
an important part of the global Olympus network, with specific responsibility for the sales and
marketing of surgical endoscopy equipment for distribution in the United States and Canada.
With a focus on innovation and quality, Olympus provides healthcare professionals with safe and
effective instrumentation to help improve clinical outcomes for the benefit of patients.




